1. Home
  2. NIVF vs HUGE Comparison

NIVF vs HUGE Comparison

Compare NIVF & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIVF
  • HUGE
  • Stock Information
  • Founded
  • NIVF 2011
  • HUGE 1998
  • Country
  • NIVF Thailand
  • HUGE Canada
  • Employees
  • NIVF N/A
  • HUGE N/A
  • Industry
  • NIVF
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NIVF
  • HUGE Health Care
  • Exchange
  • NIVF NYSE
  • HUGE Nasdaq
  • Market Cap
  • NIVF 9.8M
  • HUGE 7.8M
  • IPO Year
  • NIVF N/A
  • HUGE N/A
  • Fundamental
  • Price
  • NIVF $0.87
  • HUGE $0.15
  • Analyst Decision
  • NIVF
  • HUGE
  • Analyst Count
  • NIVF 0
  • HUGE 0
  • Target Price
  • NIVF N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • NIVF 136.3K
  • HUGE 2.6M
  • Earning Date
  • NIVF 08-16-2024
  • HUGE 09-12-2024
  • Dividend Yield
  • NIVF N/A
  • HUGE N/A
  • EPS Growth
  • NIVF N/A
  • HUGE N/A
  • EPS
  • NIVF N/A
  • HUGE N/A
  • Revenue
  • NIVF N/A
  • HUGE N/A
  • Revenue This Year
  • NIVF N/A
  • HUGE N/A
  • Revenue Next Year
  • NIVF N/A
  • HUGE N/A
  • P/E Ratio
  • NIVF N/A
  • HUGE N/A
  • Revenue Growth
  • NIVF N/A
  • HUGE N/A
  • 52 Week Low
  • NIVF $0.64
  • HUGE $0.13
  • 52 Week High
  • NIVF $17.24
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • NIVF 36.27
  • HUGE 38.67
  • Support Level
  • NIVF $0.90
  • HUGE $0.14
  • Resistance Level
  • NIVF $1.25
  • HUGE $0.16
  • Average True Range (ATR)
  • NIVF 0.08
  • HUGE 0.01
  • MACD
  • NIVF 0.00
  • HUGE 0.01
  • Stochastic Oscillator
  • NIVF 5.15
  • HUGE 58.97

About NIVF NEWGENIVF GROUP LIMITED

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: